Stocks · News reference

Citius Oncology shares are trading lower after the company reported worse-than-expected Q3 sales results.

Aug 17, 2026, 3:38 PMBenzinga Newsdesk

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Keep reading

BenzingaAug 17, 2026, 8:54 AMAvi Kapoor
Why HIVE Digital Technologies Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premarket
HIVE Digital Technologies Ltd (NASDAQ: HIVE) rose in pre-market trading due to its subsidiary's new agreement. Other gainers include IP Strategy Holdings, INVO Fertility, My Size, Trugolf Holdings, Expion360, Skye Bioscience, Julong Holding, FIEE Inc, and Keel Infrastructure. Losers include Generation Income Properties, Barfresh Food Group, iTonic Holdings, Akanda Corp, and Reservoir Media.
AKAN BRFH CGTL CTOR FIEE
BenzingaAug 14, 2026, 8:58 PMBenzinga Newsdesk
Citius Oncology Q3 EPS $(0.08), Inline, Sales $1.494M Miss $2.500M Estimate
Citius Oncology (NASDAQ:CTOR) reported quarterly losses of $(0.08) per share which met the analyst consensus estimate. This is unchanged from the same period last year. The company reported quarterly sales of $1.494
CTOR
SEC EDGARAug 14, 2026, 8:35 PMSEC EDGAR
8-K filing — CITIUS ONCOLOGY, INC. (CTOR)
Filed: 2026-08-14 AccNo: 0001213900-26-090182 Size: 332 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits
CTOR